TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
IVD Medical Holding Limited ( (HK:1931) ) has shared an announcement.
IVD Medical Holding Limited has announced a strategic cooperation with Renhe International to establish the world’s first nonprescription medicines vertical RWA exchange in the United States. This collaboration is part of IVD’s broader strategy to develop a global on-chain financial ecosystem under its ETHK brand, which includes the creation of a decentralized financial platform and a focus on digital asset transformation. The company is also proposing a name change to reflect its new positioning as a technology driver within this ecosystem. The new ‘Exchange within Exchange’ model aims to enhance global asset circulation and efficiency by creating a B2B trading ecosystem for real-world assets, thus reshaping the asset value distribution model across industries.
The most recent analyst rating on (HK:1931) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.
More about IVD Medical Holding Limited
IVD Medical Holding Limited operates in the healthcare industry, focusing on medical diagnostics and related services. The company is expanding its operations into the digital financial ecosystem through its core brand ‘ETHK’, aiming to integrate high-quality global resources with a focus on asset digitalization and financial technology applications.
Average Trading Volume: 2,422,638
Technical Sentiment Signal: Buy
Current Market Cap: HK$16.93B
For detailed information about 1931 stock, go to TipRanks’ Stock Analysis page.